| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/05/2006 | US20060223754 Human TSLP polynucleotides |
| 10/05/2006 | US20060223753 exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy |
| 10/05/2006 | US20060223751 bactericide, fungicide; defensins |
| 10/05/2006 | US20060223157 Polypeptides having nucleic acid binding activity |
| 10/05/2006 | US20060223147 Process for producing glycoprotein composition |
| 10/05/2006 | US20060223145 Method for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris |
| 10/05/2006 | US20060223144 Method for mass production of human pollicle stimulating hormone |
| 10/05/2006 | US20060223143 Methods and compositions for polypeptide engineering |
| 10/05/2006 | US20060223142 Extended cDNAs for secreted proteins |
| 10/05/2006 | US20060223141 Transcription amplification system for molecular imaging |
| 10/05/2006 | US20060223140 Transglycosylation method and protein having transglycosylation activity |
| 10/05/2006 | US20060223136 Scytalone dehydrogenase gene showing tolerance to agricultural pesticide |
| 10/05/2006 | US20060223133 Comprises immunoglobulin for treating arteriosclerosis, cancer and skin disorders; immunoassays; restenosis |
| 10/05/2006 | US20060223123 nucleic acid encoding Macaca mulatta (rhesus monkey) Nur77 nuclear receptor (rhNur77); useful for treating or inhibiting inflammatory diseases such as osteoarthritis and various bone, neurological, and prostrate disorders, and cancer; drug screening; biodrug; culturing |
| 10/05/2006 | US20060223117 Novel splice variants of human epithelial sodium channel genes expressed in human taste tissue and uses thereof |
| 10/05/2006 | US20060223115 Heterotrimeric G-protein |
| 10/05/2006 | US20060223112 Novel receptor |
| 10/05/2006 | US20060223109 G protein-coupled receptors |
| 10/05/2006 | US20060223096 Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector function |
| 10/05/2006 | US20060223093 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 10/05/2006 | US20060223090 Polynucleotides encoding human secreted proteins |
| 10/05/2006 | US20060223088 Human secreted proteins |
| 10/05/2006 | US20060223077 207 human secreted proteins |
| 10/05/2006 | US20060223067 Mutant DNA polymerases and methods of use |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222658 Vaccinia virus nucleic acids, polypeptides and immunogenic compositions |
| 10/05/2006 | US20060222654 Methods and compounds for raising antibodies and for screening antibody repertoires |
| 10/05/2006 | US20060222649 Methods for inducing antigen-specific T cell tolerance |
| 10/05/2006 | US20060222638 Cholesterol biosynthesis pathway modulators and uses thereof |
| 10/05/2006 | US20060222635 Methods and compositions for selecting cells with increased potency |
| 10/05/2006 | US20060222624 Detoxified TNF and method of preparing |
| 10/05/2006 | CA2603298A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | CA2593559A1 Polynucleotides encoding stem cell factor-like proteins |
| 10/04/2006 | EP1707634A1 Method for isolation of recombinantly produced proteins |
| 10/04/2006 | EP1707629A1 Expression system with the use of mammalian beta-actin promoter |
| 10/04/2006 | EP1707627A1 Mutants of anti-cd40 antibody |
| 10/04/2006 | EP1707626A1 Gene amplification method |
| 10/04/2006 | EP1707621A2 Mutant bioluminescent protein, and process for producing the mutant bioluminescent protein |
| 10/04/2006 | EP1707576A1 Antibodies recognizing methyllysine, process for producing the same and utilization thereof |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1706490A2 Systems for tightly regulated gene expression |
| 10/04/2006 | EP1706480A1 Modification of protein glycosylation in methylotrophic yeast |
| 10/04/2006 | EP1706428A2 Anti-cancer antibodies with reduced complement fixation |
| 10/04/2006 | EP1706139A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis |
| 10/04/2006 | EP1664300A4 A new class of a2delta calcium channel subunits |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1169461B1 Use of pancreatic procarboxypeptidase B for the production of insulin |
| 10/04/2006 | EP1027375B1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them |
| 10/04/2006 | EP1009832B1 Cytokine designated lerk-6 |
| 10/04/2006 | EP0986644B1 Production of erythropoietin by endogenous gene activation with viral promoters |
| 10/04/2006 | EP0977873B1 Method for cleavage of fusion proteins |
| 10/04/2006 | EP0783525B1 Humanized antibodies against respiratory syncytial virus |
| 10/04/2006 | CN1842709A Electrophysiological assay using oocytes that express human ENaC and the use PHENAMIL to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
| 10/04/2006 | CN1842600A A process for proteolytic cleavage and purification of recombinant proteins |
| 10/04/2006 | CN1842540A Anti-glypican 3 antibody |
| 10/04/2006 | CN1840684A Process for fermentation preparation of nosiheptide by using streptomycete |
| 10/04/2006 | CN1840683A Method for producing antibiotic peptide by using Bacillus amyloliquefaciens and product thereof |
| 10/04/2006 | CN1840682A Mass production of high activity thymosin al by genetic engineering method |
| 10/04/2006 | CN1840681A Process for producing functional soybean peptide by two-step method |
| 10/04/2006 | CN1840680A Double-enzyme process for modification preparation of injection type soybean protein isolate |
| 10/04/2006 | CN1277927C Method for preparing recombinant bFGF using domestic silkworm as biological factory |
| 10/04/2006 | CN1277921C Method for producing recombinant human lactoferrin in silkworm body by gene engineering technology |
| 10/04/2006 | CN1277844C Novel human cyclin, its coding sequence and application |
| 10/04/2006 | CN1277841C Polypeptide capable of inhibiting typhsid bacillus from invading human body cell and its preparing method |
| 10/03/2006 | US7115795 Transgenic animals expressing salivary proteins |
| 10/03/2006 | US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 |
| 10/03/2006 | US7115725 Polypeptide for use in the generation of vaccine against diphtheria toxin |
| 10/03/2006 | US7115723 Humanized antibody specific for surface antigen pre-S1 of HBV and preparation method thereof |
| 10/03/2006 | US7115717 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy |
| 10/03/2006 | US7115715 Oncogenic protein for use in the diagnosis and treatment of tumors |
| 10/03/2006 | US7115712 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12 |
| 10/03/2006 | US7115711 Retinoid X receptor-interacting polypeptides and related molecules and methods |
| 10/03/2006 | US7115562 Peptides and their use to ameliorate cell death |
| 10/03/2006 | US7115558 Anticancer, antitumor agents; brain disorders; skin disorders; polyclonal antibodies |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115415 Forstimulating or inhibiting angiogenesis and/or cardiovascularization in mammals |
| 10/03/2006 | US7115405 Recombinantly produced, enzymatically active, includes two amino acid motifs |
| 10/03/2006 | US7115404 UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1 |
| 10/03/2006 | US7115403 Expression of improved polynucleotide and polypeptide sequences encoding for eukaryotic enzymes, particularly oxidase enzymes; produced in conventional or facile expression systems. |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115397 Methods and kits for purifying his-tagged proteins |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | US7115394 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 10/03/2006 | US7115393 Melanocortin-1 receptor and methods of use |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115391 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes |
| 10/03/2006 | US7115389 Contacting L-alanine methyl ester as carboxy component and L-glutamine as amine component to an enzyme (E. coli JM 109) which catalyzes hydrolysis of amino acid ester to form a dipeptide; enzyme derived from a microorganism belonging to the genus Acetobacter |
| 10/03/2006 | US7115388 Preparing polypeptide composition originating from silk protein which has excellent touch, extensibility and cell growth-promoting activity associated with undegraded fibroin and sericin; for use in cosmetics, medicines, foods and skin care products |
| 10/03/2006 | US7115271 Protein D—an IgD-binding protein of Haemophilus influenzae |
| 10/03/2006 | US7115269 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries |
| 10/03/2006 | US7115260 Interleukin-1β converting enzyme like apoptotic protease-6 |
| 10/03/2006 | US7115258 Vesicular monoamine transporter gene therapy in parkinson's disease |
| 10/03/2006 | CA2063822C Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 09/28/2006 | WO2006102652A2 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
| 09/28/2006 | WO2006102095A2 Framework-shuffling of antibodies |
| 09/28/2006 | WO2006101474A1 Methods and compositions for producing active vitamin k-dependent proteins |
| 09/28/2006 | WO2006101023A1 Method for producing dipeptide |
| 09/28/2006 | WO2006101000A1 Anti-dermatan sulfate antibody and functional sulfated oligosaccharide |
| 09/28/2006 | WO2006100292A1 Process for microbial production of a valuable compound |